Computer Vision Quality Inspection Achievi ng 99.4% Defect Detection at 10x Throughput
A plastics manufacturer relied on manual visual inspection — slow and inconsistent. We deployed a computer vision model on the production line for real-time defect detection — achieving 99.4% accuracy at 10x throughput.
About the Client
The Challenge
A plastics manufacturer relied on manual visual inspection — slow and inconsistent. We deployed a computer vision model on the production line for real-time defect detection — achieving 99.4% accuracy at 10x throughput. The organization had reached an inflection point — production efficiency metrics were tracked in spreadsheets updated after each shift — by which time the data was already stale. Quality issues were discovered at end-of-line inspection, not during the process where they could be corrected. Supply chain visibility ended at the factory gate.
The manufacturing industry added specific complexity. OSHA safety regulations, ISO 9001/14001 standards, and FDA compliance for pharmaceutical manufacturing demanded auditable processes and governance. Any technology initiative needed to maintain compliance continuity while delivering measurable improvement. Previous attempts had stalled because vendors didn't understand these industry-specific constraints.
The executive sponsor set clear expectations: demonstrate measurable impact within one quarter. No 18-month roadmaps. No theoretical architectures. Working software, real data, measurable results — or the budget moves elsewhere. They needed a partner who could deliver ai & automation solutions with manufacturing domain expertise from day one.
Our Approach
We designed a phased approach optimized for speed-to-value while maintaining OSHA safety regulations, ISO 9001/14001 standards, and FDA compliance for pharmaceutical manufacturing continuity:
Problem Framing & Data Assessment (Weeks 1-3)
Defined AI use case with measurable success criteria. Assessed training data availability, quality, and potential bias. Established model performance benchmarks against business requirements.
Data Preparation & Feature Engineering (Weeks 2-5)
Built data pipeline for training data. Engineered features from domain expertise — the industry-specific signals that generic models miss. Data augmentation where training samples were limited.
Validation & Safety (Weeks 6-9)
Validated with domain experts on holdout data and real-world scenarios. Bias analysis and fairness assessment. Edge case testing. Performance verification against OSHA safety regulations, ISO 9001/14001 standards, and FDA compliance for pharmaceutical manufacturing requirements.
Deployment & Monitoring (Weeks 8-12)
Deployed to production with MLOps pipeline: model versioning, drift detection, and automated retraining triggers. Integrated into operational workflows where users already work.
Solution Architecture
ML Platform: Azure ML for experiment tracking, model registry, and deployment with MLOps automation
Data Pipeline: Feature engineering pipeline from source systems through feature store to model training
Production: Real-time inference endpoint with drift monitoring and automated retraining triggers
Results
Technologies Used
Key Takeaways
If your organization is facing a similar challenge, here's what we learned:
Industry context eliminates weeks of discovery. Understanding manufacturing terminology, OSHA safety regulations, ISO 9001/14001 standards, and FDA compliance for pharmaceutical manufacturing, and operational workflows meant we skipped the "teach us your business" phase. Our ai & automation team brought domain context from the first workshop.
Phased delivery maintains executive sponsorship. By delivering measurable results in 8-12 weeks, the sponsor had proof for their next board meeting. This is critical in manufacturing organizations where budget cycles are tight and competing priorities are constant.
User adoption is the real success metric. Technology implementations fail when users don't adopt. We designed the solution around existing manufacturing workflows — not the other way around. The system met users where they already worked, driving 80%+ adoption within the first month.
Ongoing governance prevents value decay. We established review cadences, defined data ownership, and built monitoring dashboards that make issues visible early. The platform continues to deliver value because governance is sustained — not because the initial deployment was perfect.
Facing a Similar Challenge?
We deliver ai & automation solutions for manufacturing organizations — with measurable outcomes typically within 8-12 weeks.